Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Sandra Statz

Senior Vice President, Clinical and Regulatory Affairs

Joined Exact Sciences: 2012

Sandra Statz has served as our Senior Vice President, Clinical and Regulatory Affairs since 2012. Prior to joining Exact Sciences, she served as Director of Clinical Operations at Quintiles and Director of Clinical Affairs at Third Wave Technologies. She holds bachelor’s and master’s degrees from the University of Wisconsin-Madison. Ms. Statz is a member of the Association of Clinical Research Professionals (ACRP), Regulatory Affairs Professionals Society (RAPS), and Medical Device Innovation Consortium (MDIC). She has also served on United Way of Dane County Cabinet Campaign and Key Club Board.